Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes.
D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000494:pharmacology; D000918:Antibody Specificity; D015704:CD4 Antigens / Q000378:metabolism / Q000494:pharmacology; D000939:Epitopes / Q000737:chemistry / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000737:chemistry* / Q000276:immunology*; D015497:HIV-1 / Q000737:chemistry / Q000276:immunology / Q000502:physiology; D008561:Membrane Fusion; D009500:Neutralization Tests; D011487:Protein Conformation; D012995:Solubility
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D000939:Epitopes; D015700:HIV Envelope Protein gp41